Thermo Fisher Scientific (TMO) PT Raised to $650 at Barclays
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $595.89 -1.18%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
Barclays analyst Luke Sergott raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $650.00 (from $625.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
- Stellantis NV (STLA:IM) (STLA) PT Lowered to EUR5 at Goldman Sachs
- Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
